See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Michelle Sholzberg

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	39571935	0	Escobar M, Lassila R, Bekdache C, et al. Use of antithrombotic therapy in patients with hemophilia: A selected synopsis of the EHA-ISTH-EAHAD-ESO Clinical Practice Guidance document. J Thromb Haemost. 2024 Nov 19:S1538-7836(24)00685-8. doi: 10.1016/j.jtha.2024.10.033.
	39495569	0	Harel Z, Smyth B, Badve SV, et al. Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial. J Am Soc Nephrol. 2024 Nov 4. doi: 10.1681/ASN.0000000000000495.
	39268352	0	Ward C, Curry N, El-Ekiaby M, et al. Erratum to 'Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress' [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]. Res Pract Thromb Haemost. 2024 Jul 13;8(5):102498. doi: 10.1016/j.rpth.2024.102498. eCollection 2024 Jul.
	38854821	0	Ward C, Curry N, El-Ekiaby M, et al. Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress. Res Pract Thromb Haemost. 2024 May 3;8(4):102432. doi: 10.1016/j.rpth.2024.102432. eCollection 2024 May.
	38623473	0	VanderMeulen H, Tang GH, Sholzberg M. Tranexamic acid for management of heavy vaginal bleeding: barriers to access and myths surrounding its use. Res Pract Thromb Haemost. 2024 Mar 19;8(3):102389. doi: 10.1016/j.rpth.2024.102389. eCollection 2024 Mar.
	38557474	0	Tapper EB, Warner MA, Shah RP, et al. Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi. Hepatology. 2024 Aug 1;80(2):488-499. doi: 10.1097/HEP.0000000000000856. Epub 2024 Apr 1.
	38503600	0	Schulman S, Arnold DM, Bradbury CA, et al. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2024 Mar 18:S1538-7836(24)00113-2. doi: 10.1016/j.jtha.2024.02.011.
	38319277	0	Fralick M, Sholzberg M. Pharmacologic Thromboprophylaxis for Patients Admitted to General Medicine - Is It Necessary? NEJM Evid. 2022 Jun;1(6):EVIDtt2200085. doi: 10.1056/EVIDtt2200085. Epub 2022 May 24.
	37538494	0	Kahn SR, Arnold DM, Casari C, et al. Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. Res Pract Thromb Haemost. 2023 Jun 21;7(4):100193. doi: 10.1016/j.rpth.2023.100193. eCollection 2023 May.
	37304933	0	Schutgens REG, Jimenez-Yuste V, Escobar M, et al. Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance. Hemasphere. 2023 Jun 5;7(6):e900. doi: 10.1097/HS9.0000000000000900. eCollection 2023 Jun.
	37063772	0	Merz LE, Siad FM, Creary M, et al. Laboratory-based inequity in thrombosis and hemostasis: review of the evidence. Res Pract Thromb Haemost. 2023 Mar 15;7(2):100117. doi: 10.1016/j.rpth.2023.100117. eCollection 2023 Feb.
	36972786	0	Thachil J, Connors JM, Mahlangu J, et al. Reclassifying hemophilia to include definition of outcomes and phenotype as new targets. J Thromb Haemost. 2023 Mar 25:S1538-7836(23)00247-7. doi: 10.1016/j.jtha.2023.03.016.
	36343959	0	Chornenki NLJ, Fralick M, Sholzberg M. Tests de depistage du rapport international normalise et du temps de cephaline activee. CMAJ. 2022 Nov 7;194(43):E1491-E1492. doi: 10.1503/cmaj.220629-f.
	36302103	0	Chornenki NLJ, Fralick M, Sholzberg M. International normalized ratio and activated partial thromboplastin time testing. CMAJ. 2022 Aug 29;194(33):E1135. doi: 10.1503/cmaj.220629.
	36223804	0	Ortega-Paz L, Talasaz AH, Sadeghipour P, et al. COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment. Semin Thromb Hemost. 2022 Oct 12. doi: 10.1055/s-0042-1757634.
	35653590	0	Baumann Kreuziger L, Sholzberg M, Cushman M. Anticoagulation in Hospitalized Patients with COVID-19. Blood. 2022 Jun 2. pii: 485455. doi: 10.1182/blood.2021014527.
	35599704	0	Nersesian S, Sholzberg M, Cushman M, et al. The Journey to a Successful Illustrated Review. Res Pract Thromb Haemost. 2022 May 18;6(4):e12721. doi: 10.1002/rth2.12721. eCollection 2022 May.
	35298939	0	Xu Y, Gomes T, Wells PS, et al. Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study. Thromb Res. 2022 Feb 24;213:57-64. doi: 10.1016/j.thromres.2022.02.018.
	34934895	0	Kamin Mukaz D, Gergi M, Koh I, et al. Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study. Res Pract Thromb Haemost. 2021 Dec 7;5(8):e12632. doi: 10.1002/rth2.12632. eCollection 2021 Dec.
	34649864	0	Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.
	34401639	0	Abdulrehman J, Zarabi S, Elbaz C, et al. Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals. Res Pract Thromb Haemost. 2021 Aug 7;5(5):e12535. doi: 10.1002/rth2.12535. eCollection 2021 Jul.
	34278187	0	Relke N, Chornenki NLJ, Sholzberg M. Tranexamic acid evidence and controversies: An illustrated review. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12546. doi: 10.1002/rth2.12546. eCollection 2021 Jul.
	34226274	0	Sholzberg M, Arnold DM, Laupacis A. Reconnaitre, traiter et signaler les cas de thrombocytopenie immunitaire thrombotique induite par un vaccin. CMAJ. 2021 Jul 5;193(26):E1031-E1033. doi: 10.1503/cmaj.210882-f.
	33990338	0	Sholzberg M, Arnold DM, Laupacis A. Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia. CMAJ. 2021 Jun 14;193(24):E913-E915. doi: 10.1503/cmaj.210882. Epub 2021 May 14.
	33741176	0	Talasaz AH, Sadeghipour P, Kakavand H, et al. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Apr 20;77(15):1903-1921. doi: 10.1016/j.jacc.2021.02.035. Epub 2021 Mar 16.
	33691765	0	Sholzberg M, Tang GH, Negri E, et al. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
	33448602	0	Tse B, Lim G, Sholzberg M, et al. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Nov;18(11):2870-2877. doi: 10.1111/jth.15027. Epub 2020 Aug 27.
	32888372	0	Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
	32866823	0	Peterson W, Liederman Z, Baker J, et al. Hemorrhagic, thrombotic and obstetric complications of congenital dysfibrinogenemia in a previously asymptomatic woman. Thromb Res. 2020 Dec;196:127-129. doi: 10.1016/j.thromres.2020.08.028. Epub 2020 Aug 19.
	32853584	0	Arnold DM, Heddle NM, Cook RJ, et al. Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. Lancet Haematol. 2020 Sep;7(9):e640-e648. doi: 10.1016/S2352-3026(20)30227-1.
	32685885	0	Elbaz C, Sholzberg M. An illustrated review of bleeding assessment tools and common coagulation tests. Res Pract Thromb Haemost. 2020 Jul 6;4(5):761-773. doi: 10.1002/rth2.12339. eCollection 2020 Jul.
	31904611	0	Khandelwal A, Phua CW, Chaudhry HR, et al. Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing. Blood Coagul Fibrinolysis. 2020 Jan;31(1):60-64. doi: 10.1097/MBC.0000000000000882.
	31796490	0	Tang GH, Norris E, Petrucci J, et al. Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study. BMJ Open. 2019 Dec 2;9(12):e032891. doi: 10.1136/bmjopen-2019-032891.
	30685874	0	Arnold DM, Jamula E, Heddle NM, et al. Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thromb Haemost. 2019 Mar;119(3):500-507. doi: 10.1055/s-0038-1677531. Epub 2019 Jan 27.
	30506352	0	Mahamad S, Chaudhry H, Nisenbaum R, et al. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients. J Thromb Thrombolysis. 2019 Feb;47(2):272-279. doi: 10.1007/s11239-018-1785-0.
	30446212	0	Yan MTS, Rydz N, Goodyear D, et al. Acquired factor XIII deficiency: A review. Transfus Apher Sci. 2018 Dec;57(6):724-730. doi: 10.1016/j.transci.2018.10.013. Epub 2018 Oct 30.
	30242329	0	Sholzberg M, Xu Y. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy. JAMA. 2018 Oct 9;320(14):1485-1486. doi: 10.1001/jama.2018.13998.
	30093248	0	Teichman J, Chaudhry HR, Sholzberg M. Novel assays in the coagulation laboratory: a clinical and laboratory perspective. Transfus Apher Sci. 2018 Aug;57(4):480-484. doi: 10.1016/j.transci.2018.07.008. Epub 2018 Jul 20.
	28399241	0	Fralick M, Sholzberg M. Coagulation Testing in a Bleeding Patient. JAMA. 2017 Apr 11;317(14):1478-1479. doi: 10.1001/jama.2017.2416.
	26914450	0	Sholzberg M, Gomes T, Juurlink DN, et al. The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation. PLoS One. 2016 Feb 25;11(2):e0149142. doi: 10.1371/journal.pone.0149142. eCollection 2016.
	26464134	0	Wood B, Sholzberg M, Ackery A. Direct oral anticoagulants and the bleeding patient. CMAJ. 2016 Feb 16;188(3):215. doi: 10.1503/cmaj.150604. Epub 2015 Oct 13.